macca and brabus, page-2

Livas, check the 300m again and the third party hovering as a "pharma network" whatever that means - more dilution is coming in 2009. Check the Sept pres.

Why should shareholders suffer due to the Opes collapse? 28m shares is $8m plus of your money - the "scientists and admin" aren't coughing up anything IMO; the Directors also get a couple of million $s in options and then shareholders are asked to particpate in contribution shares.

On market buy back?

I just don't get your optimism about Ropren - you are obviously aware of the corp. set ups in other companies. Now yoiu're looking at AIDS too?

I hope your trading her as someone is certainly not too crazy about the share price atm. At 250m shares at 30c, the diluted market cap is rather high.